[RDF data]
Home | Example Publications
PropertyValue
dcterms:bibliographicCitation <http://dblp.uni-trier.de/rec/bibtex/conf/amia/FeldmanFDBKL22>
dc:creator <https://dblp.l3s.de/d2r/resource/authors/Albert_Lin>
dc:creator <https://dblp.l3s.de/d2r/resource/authors/David_Kaplan>
dc:creator <https://dblp.l3s.de/d2r/resource/authors/Mary_Brophy>
dc:creator <https://dblp.l3s.de/d2r/resource/authors/Nathanael_Fillmore>
dc:creator <https://dblp.l3s.de/d2r/resource/authors/Nhan_V._Do>
dc:creator <https://dblp.l3s.de/d2r/resource/authors/Theodore_C._Feldman>
foaf:homepage <https://knowledge.amia.org/76677-amia-1.4637602/f008-1.4640715/f008-1.4640716/341-1.4641509/799-1.4641506>
dc:identifier DBLP conf/amia/FeldmanFDBKL22 (xsd:string)
dcterms:issued 2022 (xsd:gYear)
rdfs:label Phenotyping Hepatic Immune-Related Adverse Events After Immune Checkpoint Inhibitor Therapy. (xsd:string)
foaf:maker <https://dblp.l3s.de/d2r/resource/authors/Albert_Lin>
foaf:maker <https://dblp.l3s.de/d2r/resource/authors/David_Kaplan>
foaf:maker <https://dblp.l3s.de/d2r/resource/authors/Mary_Brophy>
foaf:maker <https://dblp.l3s.de/d2r/resource/authors/Nathanael_Fillmore>
foaf:maker <https://dblp.l3s.de/d2r/resource/authors/Nhan_V._Do>
foaf:maker <https://dblp.l3s.de/d2r/resource/authors/Theodore_C._Feldman>
dcterms:partOf <https://dblp.l3s.de/d2r/resource/publications/conf/amia/2022>
owl:sameAs <http://bibsonomy.org/uri/bibtexkey/conf/amia/FeldmanFDBKL22/dblp>
owl:sameAs <http://dblp.rkbexplorer.com/id/conf/amia/FeldmanFDBKL22>
rdfs:seeAlso <http://dblp.uni-trier.de/db/conf/amia/amia2022.html#FeldmanFDBKL22>
rdfs:seeAlso <https://knowledge.amia.org/76677-amia-1.4637602/f008-1.4640715/f008-1.4640716/341-1.4641509/799-1.4641506>
swrc:series <https://dblp.l3s.de/d2r/resource/conferences/amia>
dc:title Phenotyping Hepatic Immune-Related Adverse Events After Immune Checkpoint Inhibitor Therapy. (xsd:string)
dc:type <http://purl.org/dc/dcmitype/Text>
rdf:type swrc:InProceedings
rdf:type foaf:Document